Nuformix (LON:NFX) Trading 8.7% Higher – Time to Buy?

Shares of Nuformix plc (LON:NFX) shot up 8.7% during mid-day trading on Tuesday . The company traded as high as GBX 0.07 ($0.00) and last traded at GBX 0.06 ($0.00). 38,101,928 shares changed hands during mid-day trading, an increase of 558% from the average session volume of 5,791,018 shares. The stock had previously closed at GBX 0.06 ($0.00).

Nuformix Price Performance

The company has a 50 day moving average of GBX 0.14 and a 200-day moving average of GBX 0.17. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.12 and a quick ratio of 3.35. The company has a market cap of £512,068.75, a P/E ratio of -1.63 and a beta of 1.22.

About Nuformix

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis.